Akzo Nobel (OTCMKTS:AKZOY – Get Free Report) was the target of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 11,200 shares, a decrease of 80.2% from the October 31st total of 56,700 shares. Based on an average trading volume of 230,600 shares, the days-to-cover ratio is currently 0.0 days.
Akzo Nobel Price Performance
Shares of AKZOY traded down $0.42 during trading hours on Wednesday, reaching $19.13. 234,707 shares of the company traded hands, compared to its average volume of 139,944. The stock has a fifty day simple moving average of $21.76 and a 200 day simple moving average of $21.46. Akzo Nobel has a fifty-two week low of $19.08 and a fifty-two week high of $27.99. The stock has a market capitalization of $9.81 billion, a PE ratio of 16.16, a price-to-earnings-growth ratio of 0.68 and a beta of 1.30. The company has a quick ratio of 0.89, a current ratio of 1.21 and a debt-to-equity ratio of 0.76.
Akzo Nobel (OTCMKTS:AKZOY – Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The basic materials company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.04. The company had revenue of $2.93 billion for the quarter, compared to analysts’ expectations of $3.01 billion. Akzo Nobel had a net margin of 4.47% and a return on equity of 12.16%. As a group, research analysts predict that Akzo Nobel will post 1.45 EPS for the current fiscal year.
Akzo Nobel Cuts Dividend
About Akzo Nobel
Akzo Nobel N.V. engages in the production and sale of paints and coatings worldwide. The company operates through two segments: Decorative Paints and Performance Coatings. It offers decorative paints, including paints, lacquers, and varnishes; and a range of mixing machines and color concepts for the building and renovation industry, as well as specialty coatings.
Further Reading
- Five stocks we like better than Akzo Nobel
- Stock Sentiment Analysis: How it Works
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The Most Important Warren Buffett Stock for Investors: His Own
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How is Compound Interest Calculated?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Akzo Nobel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akzo Nobel and related companies with MarketBeat.com's FREE daily email newsletter.